CORC  > 湖南中医药大学
Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.
Zhou, Lili; Zou, Manshu; Zhu, Kun; Ning, Shuangcheng; Xia, Xinhua*
刊名Molecules (Basel, Switzerland)
2019
卷号24期号:17
关键词3-galactosidase-30-stearyl deoxyglycyrrhetinic acid asialoglycoprotein receptor cantharidin glycyrrhetinic acid hepatocellular carcinoma targeted liposomes
DOI10.3390/molecules24173080
URL标识查看原文
WOS记录号WOS:000488613700060
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5709199
专题湖南中医药大学
作者单位1.[Xia, Xinhua
2.Zhou, Lili
3.Zou, Manshu
4.Ning, Shuangcheng
5.Zhu, Kun] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Zhou, Lili,Zou, Manshu,Zhu, Kun,et al. Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.[J]. Molecules (Basel, Switzerland),2019,24(17).
APA Zhou, Lili,Zou, Manshu,Zhu, Kun,Ning, Shuangcheng,&Xia, Xinhua*.(2019).Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma..Molecules (Basel, Switzerland),24(17).
MLA Zhou, Lili,et al."Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.".Molecules (Basel, Switzerland) 24.17(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace